PDCD1 and early-onset autosomal dominant Alzheimer disease: Recent evidence indicates that the PD-1/PD-L system is also critical in reducing the inflammatory responses in CNS diseases such as stroke, multiple sclerosis (MS), and Alzheimer’s disease (AD) (Kroner et al., 2005; Ren et al., 2011b; Saresella et al., 2012).